بدائل البحث:
significantly weaker » significantly greater (توسيع البحث), significantly better (توسيع البحث), significantly related (توسيع البحث)
significantly teer » significantly better (توسيع البحث), significantly lower (توسيع البحث), significantly alter (توسيع البحث)
significantly we » significantly _ (توسيع البحث), significantly i (توسيع البحث), significantly lower (توسيع البحث)
we decrease » _ decrease (توسيع البحث), a decrease (توسيع البحث), nn decrease (توسيع البحث)
significantly weaker » significantly greater (توسيع البحث), significantly better (توسيع البحث), significantly related (توسيع البحث)
significantly teer » significantly better (توسيع البحث), significantly lower (توسيع البحث), significantly alter (توسيع البحث)
significantly we » significantly _ (توسيع البحث), significantly i (توسيع البحث), significantly lower (توسيع البحث)
we decrease » _ decrease (توسيع البحث), a decrease (توسيع البحث), nn decrease (توسيع البحث)
-
221
Structure–Activity Relationships of Azaquinazolinone Derivatives as <sup>18</sup>F‑Labeled PET Probes Targeting Ghrelin Receptors
منشور في 2025"…In a biodistribution study using normal mice, [<sup>18</sup>F]AQ-12 displayed high uptake in the pancreas, which is one of the GHSR-expressing organs, and its radioactivity was significantly decreased by coinjection with unlabeled AQ-12. …"
-
222
Projected global leukemia burden, 1990-2050.
منشور في 2025"…Methods: From 1990 to 2021, we analyzed age-standardized rates (ASR) trends across 204 countries and territories, utilizing the estimated annual percentage change (EAPC). …"
-
223
Correlation between HDI and EAPC.
منشور في 2025"…Methods: From 1990 to 2021, we analyzed age-standardized rates (ASR) trends across 204 countries and territories, utilizing the estimated annual percentage change (EAPC). …"
-
224
Global leukemia incidence and EAPC, 1990-2021.
منشور في 2025"…Methods: From 1990 to 2021, we analyzed age-standardized rates (ASR) trends across 204 countries and territories, utilizing the estimated annual percentage change (EAPC). …"
-
225
Participant retention flowchart.
منشور في 2025"…We identified a 4-class solution: (1) severe with appetite decrease, (2) severe with appetite increase, (3) moderate severity and (4) low severity. …"
-
226
DataSheet1_The OsGAPC3 mutation significantly affects grain quality traits and improves the nutritional quality of rice.docx
منشور في 2024"…The number and volume of type-II protein bodies in the endosperm of the OsGAPC3 mutants, and GPC increase significantly. We report significant increases in chalkiness area and degree, and decreases for starch content, gel consistency, and taste value. …"
-
227
Raw data.
منشور في 2025"…Biomechanical results revealed that the ROM of the surgical segment had decreased significantly under six basic working conditions following NZ implantation. …"
-
228
Cohort characteristics.
منشور في 2024"…</p><p>Results</p><p>The analysis reveals a significant decrease in all health services utilization from 2016 to 2019, followed by an increase until 2022. …"
-
229
Table 1_Dual variants of uncertain significance in a case of hyper-IgM syndrome: implications for diagnosis and management.docx
منشور في 2025"…</p>Objective<p>This study aims to elucidate the clinical implications of concurrent AICDA and IKBKB homozygous variants in a pediatric patient diagnosed with hyper-IgM syndrome.</p>Methods<p>We present immunological and genetic analysis of a Tunisian patient with two homozygous variants of uncertain significance (VUSs) in the IKBKB and AICDA genes, suspected of causing hyper-IgM and immune deficiency. …"
-
230
Image 2_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.jpeg
منشور في 2025"…Ibogaine, a psychoactive alkaloid, has been proposed as a potential neuroregenerative agent due to its multifaceted pharmacological profile. We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …"
-
231
Image 1_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.jpeg
منشور في 2025"…Ibogaine, a psychoactive alkaloid, has been proposed as a potential neuroregenerative agent due to its multifaceted pharmacological profile. We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …"
-
232
Summary of measured parameters.
منشور في 2025"…Male KO mice also displayed a significant decrease in rearing activity and blood pressure. …"
-
233
Raw data.
منشور في 2025"…Male KO mice also displayed a significant decrease in rearing activity and blood pressure. …"
-
234
S1 Graphical abstract -
منشور في 2025"…</p><p>Conclusions</p><p>Our analysis showed a significant decrease in mortality from paroxysmal tachycardia since 1999, although there has been a slight increase in recent years. …"
-
235
Flowchart of patient selection in this study.
منشور في 2024"…Among the letrozole-treated patients, the mean FIB-4 index tended to decline during letrozole treatment; a significant decrease was observed at 18 and 24 months compared with the baseline values (p = 0.044 and p = 0.013). …"
-
236
S1 Data -
منشور في 2024"…Among the letrozole-treated patients, the mean FIB-4 index tended to decline during letrozole treatment; a significant decrease was observed at 18 and 24 months compared with the baseline values (p = 0.044 and p = 0.013). …"
-
237
DataSheet1_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF
منشور في 2024"…Further, data from sleep questionnaires proved sleep-wake disruption in patients with MASLD. We objectively assessed sleep-wake rhythms in patients with biopsy-proven MASLD (n = 35) and healthy controls (HC, n = 16) using actigraphy 24/7 for 4 weeks. …"
-
238
DataSheet3_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF
منشور في 2024"…Further, data from sleep questionnaires proved sleep-wake disruption in patients with MASLD. We objectively assessed sleep-wake rhythms in patients with biopsy-proven MASLD (n = 35) and healthy controls (HC, n = 16) using actigraphy 24/7 for 4 weeks. …"
-
239
DataSheet2_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF
منشور في 2024"…Further, data from sleep questionnaires proved sleep-wake disruption in patients with MASLD. We objectively assessed sleep-wake rhythms in patients with biopsy-proven MASLD (n = 35) and healthy controls (HC, n = 16) using actigraphy 24/7 for 4 weeks. …"
-
240
DataSheet4_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF
منشور في 2024"…Further, data from sleep questionnaires proved sleep-wake disruption in patients with MASLD. We objectively assessed sleep-wake rhythms in patients with biopsy-proven MASLD (n = 35) and healthy controls (HC, n = 16) using actigraphy 24/7 for 4 weeks. …"